UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2000, Oxford monographs on medical genetics, ISBN 9780195128307, Volume no. 40., xx, 639
Book
American journal of clinical pathology, ISSN 0002-9173, 05/2020, Volume 153, Issue 6, pp. 715 - 718
Life Sciences & Biomedicine | Pathology | Science & Technology | Betacoronavirus - isolation & purification | Specimen Handling - economics | COVID-19 Testing | Coronavirus Infections - diagnosis | Coronavirus Infections - economics | Humans | Specimen Handling - methods | Specimen Handling - standards | Clinical Laboratory Techniques - instrumentation | Clinical Laboratory Techniques - standards | Clinical Laboratory Techniques - methods | Reverse Transcriptase Polymerase Chain Reaction - economics | SARS-CoV-2 | RNA, Viral - genetics | Medical Laboratory Personnel - economics | RNA, Viral - isolation & purification | Betacoronavirus - genetics | Clinical Laboratory Techniques - economics | Polymerase chain reaction | Usage | Health services administration | Management | Methods | Diagnostic specimens | Quality management | Severe acute respiratory syndrome coronavirus 2 | Ribonucleic acid--RNA | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1012 - 1019
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Pneumology | Quality-Adjusted Life Years | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - chemistry | Lung Neoplasms - chemistry | Biomarkers, Tumor - analysis | Gene Frequency | Humans | Antineoplastic Agents - therapeutic use | Pyrazoles - economics | Antineoplastic Agents - economics | Carcinoma, Non-Small-Cell Lung - economics | Oncogene Proteins, Fusion - analysis | Oncogene Proteins, Fusion - genetics | Cost-Benefit Analysis | Sensitivity and Specificity | Pyridines - economics | Lung Neoplasms - economics | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Ontario | Immunohistochemistry - economics | Pyridines - therapeutic use | Index Medicus
Journal Article
Prenatal diagnosis, ISSN 0197-3851, 07/2016, Volume 36, Issue 7, pp. 636 - 642
Genetics & Heredity | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Muscular Atrophy, Spinal - diagnosis | Amniocentesis - economics | Humans | Genetic Diseases, Inborn - genetics | Adrenal Hyperplasia, Congenital - genetics | Molecular Diagnostic Techniques - economics | DNA - blood | Muscular Atrophy, Spinal - genetics | Thanatophoric Dysplasia - diagnosis | Adrenal Hyperplasia, Congenital - diagnosis | Prenatal Diagnosis - economics | Genetic Counseling - economics | Female | Hemophilia A - diagnosis | Genetic Diseases, Inborn - diagnosis | Thanatophoric Dysplasia - genetics | Chorionic Villi Sampling - economics | Achondroplasia - genetics | Costs and Cost Analysis | Counseling - economics | Specimen Handling - economics | Achondroplasia - diagnosis | United Kingdom | Pregnancy | Hemophilia A - genetics | Anemia, Sickle Cell - diagnosis | Muscular Dystrophy, Duchenne - genetics | Sequence Analysis, DNA - economics | Anemia, Sickle Cell - genetics | Muscular Dystrophy, Duchenne - diagnosis | Genetic research | Sickle cell anemia | Pregnant women | Analysis | Genes | Index Medicus | Original
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 01/2013, Volume 11, Issue 1, pp. 81 - 91
clopidogrel | cost‐effectiveness | prasugrel | antiplatelet therapy | genetic testing | acute coronary syndromes | Antiplatelet therapy | Prasugrel | Clopidogrel | Genetic testing | Acute coronary syndromes | Cost-effectiveness | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Prasugrel Hydrochloride | Predictive Value of Tests | Thiophenes - therapeutic use | Percutaneous Coronary Intervention - mortality | Acute Coronary Syndrome - economics | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Thiophenes - metabolism | Medicare - economics | Models, Economic | Pharmacogenetics - economics | Time Factors | Ticlopidine - economics | Myocardial Infarction - etiology | Insurance, Health, Reimbursement - economics | Quality-Adjusted Life Years | Genetic Predisposition to Disease | Risk Assessment | Gene Frequency | Risk Factors | Piperazines - therapeutic use | Ticlopidine - analogs & derivatives | Phenotype | Acute Coronary Syndrome - therapy | Thrombosis - genetics | Percutaneous Coronary Intervention - economics | Percutaneous Coronary Intervention - adverse effects | Thrombosis - economics | Drug Costs | Platelet Aggregation Inhibitors - economics | Markov Chains | Ticlopidine - therapeutic use | United States | Acute Coronary Syndrome - mortality | Piperazines - economics | Piperazines - metabolism | Computer Simulation | Hemorrhage - etiology | Ticlopidine - metabolism | Thiophenes - economics | Platelet Aggregation Inhibitors - metabolism | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Decision Support Techniques | Kaplan-Meier Estimate | Treatment Outcome | Cerebrovascular Disorders - etiology | Aryl Hydrocarbon Hydroxylases - metabolism | Disease-Free Survival | Health Care Costs | Cytochrome P-450 CYP2C19 | Cost-Benefit Analysis | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - genetics | Genetic Testing - economics | Transluminal angioplasty | Care and treatment | Medicare | Analysis | Cardiac patients | Cytochrome P-450 | Markov processes | Cost benefit analysis | Coronary heart disease | Genetic screening | Angina pectoris | Genotype & phenotype | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 06/2012, Volume 97, Issue 6, pp. 1905 - 1912
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Non tumoral diseases. Target tissue resistance. Benign neoplasms | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Vertebrates: endocrinology | Thyroid. Thyroid axis (diseases) | Biological and medical sciences | Endocrinopathies | Medical sciences | Thyroid Neoplasms - surgery | Adenoma, Oxyphilic - surgery | Unnecessary Procedures - economics | Adenoma, Oxyphilic - pathology | Humans | Thyroid Nodule - economics | Preoperative Care - economics | Thyroidectomy - methods | Thyroid Neoplasms - economics | Algorithms | Thyroid Nodule - pathology | Biopsy, Fine-Needle - economics | Cost-Benefit Analysis | Adenoma, Oxyphilic - economics | Thyroidectomy - economics | Decision Trees | Genetic Testing - economics | Thyroid Nodule - surgery | Thyroid Neoplasms - pathology | Index Medicus | Abridged Index Medicus | 12 | 5 | Endocrine Care
Journal Article
1996, ISBN 9780867204834, xvi, 304
Book
Current diabetes reports, ISSN 1534-4827, 5/2019, Volume 19, Issue 5, pp. 1 - 7
MODY | Medicine & Public Health | Monogenic diabetes | Diabetes | Genetic testing | Cost-effectiveness | CEA | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diabetes Mellitus, Type 1 - genetics | High-Throughput Nucleotide Sequencing | Genetic Testing | Mutation | Diabetes Mellitus, Type 2 - genetics | Humans | Type 2 diabetes | Gene mutations | Analysis | Diagnosis | Medical screening | Cost benefit analysis | Genetic screening | Medical care, Cost of | Cost reduction | Index Medicus
Journal Article
PharmacoEconomics, ISSN 1170-7690, 8/2016, Volume 34, Issue 8, pp. 771 - 793
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Pharmacology & Pharmacy | Business & Economics | Health Policy & Services | Science & Technology | Pharmacogenetics - economics | Pharmacogenetics - methods | Drug-Related Side Effects and Adverse Reactions - prevention & control | Cost-Benefit Analysis | Humans | Genotype | Drug-Related Side Effects and Adverse Reactions - economics | Pharmacogenomic Testing - economics | Pharmacogenomic Testing - methods | Drug-Related Side Effects and Adverse Reactions - epidemiology | Incidence | Drugs | Prevention | Pharmaceutical research | Economic aspects | Adverse and side effects | Genetic screening | Side effects
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 10/2016, Volume 53, Issue 10, pp. 655 - 661
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Genetic Predisposition to Disease | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Aged, 80 and over | Carcinoma, Ovarian Epithelial | Germ-Line Mutation | Adult | Female | Aged | Genetic Testing - economics | Neoplasms, Glandular and Epithelial - diagnosis | BRCA2 Protein - genetics | Women | Care and treatment | BRCA mutations | Genetic aspects | Research | Health aspects | Ovarian cancer | Index Medicus | counselling | Obstetrics and Gynaecology | Clinical genetics | Cancer Genetics | 1506 | Genetic screening
Journal Article